Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
Public ClinicalTrials.gov record NCT00241514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was a multicentre, double-blind, randomised, placebo-controlled parallel group study consisting of 4 visits over a period of 6 months. The primary variable was to assess the efficacy of esomeprazole 40 mg orally qd (E40) or esomeprazole 20 mg orally qd (E20) versus placebo orally qd after 6 months of treatment for the prevention of relapse of upper GI symptoms associated with NSAID use, including COX-2 selective NSAIDs, in patients receiving daily NSAID therapy.
Study identification
- NCT ID
- NCT00241514
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 334 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2001 (Type not available)
- Primary completion
- Feb 2003 (Actual)
- Completion
- Feb 2003 (Actual)
- Last update posted
- Jan 21, 2011
2001 – 2003
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | San Francisco | California | — | — |
| Research Site | Bradenton | Florida | — | — |
| Research Site | Clearwater | Florida | — | — |
| Research Site | Fort Lauderdale | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | South Miami | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Zephyrhills | Florida | — | — |
| Research Site | Conyers | Georgia | — | — |
| Research Site | Newburgh | Indiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Tulsa | Oklahoma | — | — |
| Research Site | Tipton | Pennsylvania | — | — |
| Research Site | Norfolk | Virginia | — | — |
| Research Site | Virginia Beach | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00241514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2011 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00241514 live on ClinicalTrials.gov.